Development and validation of a hierarchical approach for lymphoma classification using immunohistochemical markers

Documenti analoghi

• Revisiting beta‐2 microglobulin as a prognostic marker in diffuse large B‐cell lymphoma
  di: Jelena Jelicic, et al.
  Pubblicazione: (2024)
• Machine learning‐based model constructed from ultrasound radiomics and clinical features for predicting HER2 status in breast cancer patients with indeterminate (2+) immunohistochemical results
  di: Meiying Yan, et al.
  Pubblicazione: (2024)
• Caucasian validation of downstaging from IIB to IIA in T1N1M0 patients within the 9th edition of the non‐small cell lung cancer tumor‐node‐metastasis staging
  di: Jingsheng Cai, et al.
  Pubblicazione: (2024)
• Current Knowledge of Immune Checkpoint Inhibitor‐Induced Thrombocytopenia: Epidemiology, Mechanisms, and Management
  di: Youran Dai, et al.
  Pubblicazione: (2026)
• Gut Roseburia is a protective marker for peritoneal metastasis of gastric cancer
  di: Dandan Yu, et al.
  Pubblicazione: (2024)